Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women

NCT00755417 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

541

Enrollment

INDUSTRY

Sponsor class

Conditions

Hot Flashes

Interventions

DRUG: Gabapentin Extended-Release (G-ER) 1200 mg
DRUG: Gabapentin Extended-Release (G-ER) 1800 mg
DRUG: Placebo

Sponsor

Depomed